BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21145788)

  • 1. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
    Kempers MJ; Kuiper RP; Ockeloen CW; Chappuis PO; Hutter P; Rahner N; Schackert HK; Steinke V; Holinski-Feder E; Morak M; Kloor M; Büttner R; Verwiel ET; van Krieken JH; Nagtegaal ID; Goossens M; van der Post RS; Niessen RC; Sijmons RH; Kluijt I; Hogervorst FB; Leter EM; Gille JJ; Aalfs CM; Redeker EJ; Hes FJ; Tops CM; van Nesselrooij BP; van Gijn ME; Gómez García EB; Eccles DM; Bunyan DJ; Syngal S; Stoffel EM; Culver JO; Palomares MR; Graham T; Velsher L; Papp J; Oláh E; Chan TL; Leung SY; van Kessel AG; Kiemeney LA; Hoogerbrugge N; Ligtenberg MJ
    Lancet Oncol; 2011 Jan; 12(1):49-55. PubMed ID: 21145788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
    Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.
    Lynch HT; Riegert-Johnson DL; Snyder C; Lynch JF; Hagenkord J; Boland CR; Rhees J; Thibodeau SN; Boardman LA; Davies J; Kuiper RP; Hoogerbrugge N; Ligtenberg MJ
    Am J Gastroenterol; 2011 Oct; 106(10):1829-36. PubMed ID: 21769135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
    Ligtenberg MJ; Kuiper RP; Geurts van Kessel A; Hoogerbrugge N
    Fam Cancer; 2013 Jun; 12(2):169-74. PubMed ID: 23264089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
    Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
    Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.
    Rumilla K; Schowalter KV; Lindor NM; Thomas BC; Mensink KA; Gallinger S; Holter S; Newcomb PA; Potter JD; Jenkins MA; Hopper JL; Long TI; Weisenberger DJ; Haile RW; Casey G; Laird PW; Le Marchand L; Thibodeau SN
    J Mol Diagn; 2011 Jan; 13(1):93-9. PubMed ID: 21227399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
    Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
    Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
    Kuiper RP; Vissers LE; Venkatachalam R; Bodmer D; Hoenselaar E; Goossens M; Haufe A; Kamping E; Niessen RC; Hogervorst FB; Gille JJ; Redeker B; Tops CM; van Gijn ME; van den Ouweland AM; Rahner N; Steinke V; Kahl P; Holinski-Feder E; Morak M; Kloor M; Stemmler S; Betz B; Hutter P; Bunyan DJ; Syngal S; Culver JO; Graham T; Chan TL; Nagtegaal ID; van Krieken JH; Schackert HK; Hoogerbrugge N; van Kessel AG; Ligtenberg MJ
    Hum Mutat; 2011 Apr; 32(4):407-14. PubMed ID: 21309036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
    Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
    J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients.
    Guarinos C; Castillejo A; Barberá VM; Pérez-Carbonell L; Sánchez-Heras AB; Segura A; Guillén-Ponce C; Martínez-Cantó A; Castillejo MI; Egoavil CM; Jover R; Payá A; Alenda C; Soto JL
    J Mol Diagn; 2010 Nov; 12(6):765-70. PubMed ID: 20864635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.
    Huth C; Kloor M; Voigt AY; Bozukova G; Evers C; Gaspar H; Tariverdian M; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Mod Pathol; 2012 Jun; 25(6):911-6. PubMed ID: 22388758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.
    Eguchi H; Kumamoto K; Suzuki O; Kohda M; Tada Y; Okazaki Y; Ishida H
    Jpn J Clin Oncol; 2016 Feb; 46(2):178-84. PubMed ID: 26613680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.
    Mur P; Pineda M; Romero A; Del Valle J; Borràs E; Canal A; Navarro M; Brunet J; Rueda D; Ramón Y Cajal T; Lázaro C; Caldés T; Blanco I; Soto JL; Capellá G
    Clin Genet; 2014 Mar; 85(3):260-6. PubMed ID: 23530899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
    Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
    Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPCAM deletions, Lynch syndrome, and cancer risk.
    Lynch HT; Lynch JF; Snyder CL; Riegert-Johnson D
    Lancet Oncol; 2011 Jan; 12(1):5-6. PubMed ID: 21195320
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
    Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
    Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
    Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
    J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.